William Roberts | VP, IR & Corporate Communications |
John Bailey | CEO, President & Director |
Jennifer Moses | CFO |
Rajesh Malik | Chief Medical Officer and SVP of R&D |
Chad Messer | Needham & Company |
Joseph Thome | Cowen and Company |
Thomas Shrader | BTIG |
David Nierengarten | Wedbush Securities |
Tony Butler | Roth Castle |
Good day. Thank you for standing by, and welcome to the G1 Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions].